BRUSSELS, March 5 (Reuters) - Philips won permission from the European Commission on Wednesday to buy U.S. sleep therapy products maker Respironics Inc for $5.1 billion, its largest deal to date in the fast-growing health-care sector.
BRUSSELS, March 5 (Reuters) - Philips won permission from the European Commission on Wednesday to buy U.S. sleep therapy products maker Respironics Inc for $5.1 billion, its largest deal to date in the fast-growing health-care sector.
